Vanda Pharmaceuticals Inc.
VNDA | NASDAQ
$5.21
+$0.05 (+1.07%)
Sep 22, 2026, 1:34 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -111.08M | -48.57M | -141.19M | -22.59M | -27.21M | -29.49M | -4.91M | -5.32M | -4.52M | -4.15M | -2.4M | 137K | 1.52M | 3.25M | 6.86M | 3.27M | 2.57M | -6.43M | 7.08M | 7.77M | 9.65M | 8.65M |
Depreciation & Amortization | 7.23M | 3.53M | 5.86M | 2.05M | -2.79M | 1.98M | 1.97M | 1.97M | 1.97M | 2.22M | 1.16M | 580K | 602K | 670K | 663K | 678K | 690K | 702K | 706K | 708K | 712K | 715K |
Stock-Based Compensation | 4.67M | 2.56M | 2.29M | 2.11M | 2.11M | 2.97M | 2.86M | 3M | 2.99M | 3.58M | 3.27M | 3.17M | 3.25M | 4.35M | 3.78M | 3.89M | 3.83M | 4.78M | 3.77M | 3.95M | 3.74M | 3.91M |
Other Working Capital | 10.55M | -7.33M | -696K | 7.63M | 4.71M | -8.23M | 7.38M | -8.13M | -2.85M | 8.37M | 4.75M | -10.27M | -6.62M | 23.86M | 7.13M | 8.38M | -1.41M | -14.25M | 1.91M | -1.31M | 3.1M | 699K |
Other Non-Cash Items | 594K | 144K | -2.59M | 895K | 5.29M | 1.1M | -545K | -1.49M | -1.52M | -825K | -1.1M | -1.88M | -1.22M | -524K | -959K | -521K | 344K | 629K | 704K | 991K | 897K | 773K |
Deferred Income Tax | n/a | n/a | 103.19M | -5.97M | -7.97M | -7.8M | -1.91M | -3.09M | -1.23M | -246K | -7.48M | 2.73M | 1.46M | 2.01M | 417K | -1.84M | -1.87M | 4.42M | 1.31M | 2.53M | 1.75M | 1.16M |
Change in Working Capital | 17.3M | -7.89M | 3.03M | -8.13M | 15.32M | -1.91M | 718K | -9.64M | -4.61M | 6.98M | 2.82M | -6.78M | -18.83M | 22.04M | -1.35M | 7.36M | 114K | -50K | 13.03M | -6.55M | 2.27M | -6.01M |
Operating Cash Flow | -81.29M | -50.22M | -29.42M | -31.63M | -15.25M | -33.15M | -1.82M | -14.58M | -6.93M | 7.57M | -3.73M | -2.05M | -13.22M | 31.8M | 9.42M | 12.84M | 5.69M | 4.05M | 26.61M | 9.4M | 19.02M | 9.19M |
Capital Expenditures | -411K | -221K | -102K | -161K | -299K | -436K | -214K | -161K | -108K | -7K | -253K | -24K | -55K | -51K | -263K | -148K | -193K | -75K | -134K | 10K | -298K | -130K |
Cash Acquisitions | -10M | -10M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.71M | n/a | -35.35M | 190.84M | 655K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | -2.03M | -14.05M | -52.97M | -43.33M | -92.4M | -83.73M | -112.63M | -76.01M | -54.98M | -46.65M | -247.93M | -163.05M | -4.31M | -168.96M | -96.85M | -79.13M | -105.27M | -117.84M | -104.29M | -93.06M |
Sales Maturities Of Investments | 64.46M | 30.46M | 47M | 35.57M | 38M | 87.67M | 96.61M | 95.95M | 99M | 60.5M | 112.11M | 82M | 57.1M | 350.39M | 80M | 147.34M | 82.45M | 90.08M | 79.41M | 101.24M | 70.41M | 93.26M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.52M | n/a | -100.67M | 35.35M | -190.84M | -655K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 54.04M | 20.23M | 44.87M | 21.36M | -15.27M | 43.9M | 3.99M | 12.06M | -15.26M | -18.22M | -43.78M | 35.33M | -190.89M | 187.29M | 75.43M | -21.78M | -14.59M | 10.87M | -26M | -16.59M | -34.18M | 71K |
Debt Repayment | -1.63M | -776K | -640K | -517K | -425K | -409K | -155K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | -915K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | -1.63M | -776K | -640K | -517K | -425K | -1.32M | -155K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 605K | 4K | 125K | n/a | 1.04M | 371K | 289K | 1.85M |
Net Cash Flow | -28.97M | -30.92M | 14.93M | -10.96M | -30.81M | 9.48M | 1.82M | -2.46M | -22.21M | -10.66M | -47.37M | 33.16M | -204.14M | 219.14M | 85.63M | -8.83M | -8.7M | 14.86M | 1.55M | -6.78M | -14.89M | 11.1M |
Free Cash Flow | -81.7M | -50.44M | -29.52M | -31.79M | -15.55M | -33.58M | -2.03M | -14.74M | -7.04M | 7.56M | -3.99M | -2.07M | -13.28M | 31.75M | 9.15M | 12.69M | 5.49M | 3.97M | 26.47M | 9.41M | 18.72M | 9.06M |
Adj. Free Cash Flow | -86.37M | -53M | -31.8M | -33.9M | -17.66M | -36.55M | -4.89M | -17.74M | -10.02M | 3.98M | -7.26M | -5.24M | -16.52M | 27.4M | 5.37M | 8.8M | 1.66M | -807K | 22.7M | 5.46M | 14.98M | 5.15M |
Maintenance CapEx | -411K | -221K | n/a | n/a | -182.62K | -294.16K | n/a | n/a | n/a | -7K | -253K | -24K | -55K | n/a | -263K | -148K | -193K | -75K | -117.47K | 20K | -40.95K | n/a |
Growth CapEx | n/a | n/a | -102K | -161K | -116.38K | -141.85K | -214K | -161K | -108K | n/a | n/a | n/a | n/a | -51K | n/a | n/a | n/a | n/a | -16.53K | -10K | -257.05K | -130K |
Owner Earnings | -81.7M | -50.44M | -29.42M | -31.63M | -15.43M | -33.44M | -1.82M | -14.58M | -6.93M | 7.56M | -3.99M | -2.07M | -13.28M | 31.8M | 9.15M | 12.69M | 5.49M | 3.97M | 26.49M | 9.42M | 18.98M | 9.19M |
Add to Watchlist
Select watchlists to add or remove VNDA